Hosted on MSN2mon
FDA approves Qelbree label update for ADHD treatmentDespite the overall strong performance, the company's legacy products, Trokendi XR and Oxtellar XR, saw a decline in net sales. The company's Q3 net product sales also rose significantly to $170.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback